Congress to take another look at FDA modernization

Congressional aides have begun preparing for reauthorization of the 1997 FDA Modernization Act, the most sweeping legislation the agency has ever had to deal with.

The modernization act, which began as an effort to revise a 1992 law on FDA fees and became a large-scale overhaul reaching into every FDA department, is scheduled for renewal beginning this year.

Observers suggest that the politics surrounding the FDA and the forthcoming reauthorization could be--well, interesting, given the Bush administration's ties to the pharmaceutical industry.

"I wouldn't be surprised in this shining light of bipartisanship that it would get a lot more attention than it might have in the past," said one Democratic House aide.

The first provision to be reviewed is one based on legislation by Sens. Christopher Dodd, D-Conn., and Mike DeWine, R-Ohio. It would entice companies to improve research on the effects of drugs on children by offering six months' marketing time free from competition.

A January FDA report said that while the provision has worked well--resulting in 58 studies completed and exclusivity granted to 25 drugs in the past three years, with hundreds more in the pipeline--it could be better.

Dodd will focus on finding a way to encourage studies on drugs that are already off-patent and for which there is no monetary incentive.

Although most of the modernization act will not be up for review until 2002, some Democrats hope to bring up drug advertising, post-drug approval study commitments and expansion of review fees during the pediatric provision hearings expected later this year.

House Energy and Commerce Health Subcommittee ranking member Sherrod Brown, D-Ohio, said recently that Democrats also are contemplating raising drug-patent fairness issues and "the things drug companies use to keep generics out [of the market]."

The modernization act reauthorization could be a vehicle for comprehensive review of drug patents. But some aides warn that such controversial issues should not be loaded onto the pediatrics provision, lest it collapse under the political weight.

House and Senate Republicans have begun laying the groundwork for the reform bill and exploring how well the previous legislation has worked. "We've experienced a slowdown in drug approvals, and we want to find out why," said a spokesman for Energy and Commerce Chairman Tauzin.

Despite the primacy of drug issues, the modernization act went far beyond drugs, addressing how FDA regulates new medical-device technology--such as pacemakers and shunts, blood and tissue products, veterinary medicine reviews, and food and packaging substances.

"Anything anybody's been saving up for the past five years on drugs or devices, I imagine they'll look to this bill," said a Senate aide.

Stay up-to-date with federal news alerts and analysis — Sign up for GovExec's email newsletters.
Close [ x ] More from GovExec

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • Sponsored by Brocade

    Best of 2016 Federal Forum eBook

    Earlier this summer, Federal and tech industry leaders convened to talk security, machine learning, network modernization, DevOps, and much more at the 2016 Federal Forum. This eBook includes a useful summary highlighting the best content shared at the 2016 Federal Forum to help agencies modernize their network infrastructure.

  • Sponsored by CDW-G

    GBC Flash Poll Series: Merger & Acquisitions

    Download this GBC Flash Poll to learn more about federal perspectives on the impact of industry consolidation.

  • Sponsored by One Identity

    One Nation Under Guard: Securing User Identities Across State and Local Government

    In 2016, the government can expect even more sophisticated threats on the horizon, making it all the more imperative that agencies enforce proper identity and access management (IAM) practices. In order to better measure the current state of IAM at the state and local level, Government Business Council (GBC) conducted an in-depth research study of state and local employees.

  • Sponsored by Aquilent

    The Next Federal Evolution of Cloud

    This GBC report explains the evolution of cloud computing in federal government, and provides an outlook for the future of the cloud in government IT.

  • Sponsored by Aquilent

    A DevOps Roadmap for the Federal Government

    This GBC Report discusses how DevOps is steadily gaining traction among some of government's leading IT developers and agencies.

  • Sponsored by LTC Partners, administrators of the Federal Long Term Care Insurance Program

    Approaching the Brink of Federal Retirement

    Approximately 10,000 baby boomers are reaching retirement age per day, and a growing number of federal employees are preparing themselves for the next chapter of their lives. Learn how to tackle the challenges that today's workforce faces in laying the groundwork for a smooth and secure retirement.

  • Sponsored by Hewlett Packard Enterprise

    Cyber Defense 101: Arming the Next Generation of Government Employees

    Read this issue brief to learn about the sector's most potent challenges in the new cyber landscape and how government organizations are building a robust, threat-aware infrastructure

  • Sponsored by Aquilent

    GBC Issue Brief: Cultivating Digital Services in the Federal Landscape

    Read this GBC issue brief to learn more about the current state of digital services in the government, and how key players are pushing enhancements towards a user-centric approach.

  • Sponsored by CDW-G

    Joint Enterprise Licensing Agreements

    Read this eBook to learn how defense agencies can achieve savings and efficiencies with an Enterprise Software Agreement.

  • Sponsored by Cloudera

    Government Forum Content Library

    Get all the essential resources needed for effective technology strategies in the federal landscape.


When you download a report, your information may be shared with the underwriters of that document.